Andere talen Vivesto AB

Aandelen

VIVE

SE0000722365

Beurs gesloten - Nasdaq Stockholm Andere beurzen 17:22:11 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,2935 ^SEK	+4,82%		-4,40%	-27,98%

26/03	Transcript : Vivesto AB - Special Call
07/03	Vivesto AB geeft eerste patiënt in klinische Paccal Vet studie	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Notice of Annual General Meeting in Vivesto AB	23/04
Vivesto to hold live-streamed Paccal Vet R&D Update on March 26	19/03
Vivesto doses first patient in its clinical Paccal Vet trial	07/03
Vivesto AB Doses First Patient in its Clinical Paccal Vet Trial	07/03
Vivesto AB Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
Vivesto's international patent application for XR-18 receives positive decision	30/01
Vivesto's International Patent Application for XR-18 Receives Positive Decision	30/01
Vivesto Gains on Receipt of US Approval for Pilot Clinical Trial of Drug Candidate Paccal Vet	28/12
Vivesto’s US clinical Paccal Vet trial receives approval to start patient recruitment	28/12
Vivesto AB's US Clinical Paccal Vet Trial Receives Approval to Start Patient Recruitment	28/12
Vivesto’s Paccal Vet granted FDA MUMS designation	22/12
Vivesto makes impairment charge following withdrawal of European market authorizations for Apealea	22/12
Vivesto AB Reports Positive Preclinical Data Supporting Continued Development of Cantrixil	19/12
Vivesto reports positive preclinical data supporting continued development of Cantrixil	19/12
Nomination Committee appointed for the 2024 Annual General Meeting in Vivesto	23/11
Vivesto AB Announces Composition of Nomination Committee	23/11
Vivesto Abandons Apealea Partnership with Elevar Therapeutics	23/11
Vivesto and Elevar sign agreement ending Apealea® partnership	23/11
Vivesto AB and Elevar Therapeutics Inc. Sign Agreement Ending Apealea®? Partnership	23/11
Interim report for the period January 1, 2023 – September 30, 2023	16/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Vivesto AB

Aandelen

VIVE

SE0000722365

Andere talen

Filters